Patents by Inventor Angella Nzonza

Angella Nzonza has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Recombinant novirhabdovirus usable as an antigen vector
    Patent number: 9907843
    Abstract: The invention relates to a recombinant novirhabdovirus expressing a chimeric protein comprising the sequence of an antigen of interest flanked, at the N-terminus, by a signal peptide, and at the C-terminus, by a polypeptide comprising at least one portion of the transmembrane domain of a rhabdovirus G protein. Said recombinant novirhabdovirus can be used especially for inducing an immune response to the antigen of interest.
    Type: Grant
    Filed: October 8, 2013
    Date of Patent: March 6, 2018
    Assignee: Institut National de la Recherche Agronomique
    Inventors: Michel Bremont, Angella Nzonza
  • Recombinant Novirhabdovirus Usable as an Antigen Vector
    Publication number: 20150265699
    Abstract: The invention relates to a recombinant novirhabdovirus expressing a chimeric protein comprising the sequence of an antigen of interest flanked, at the N-terminus, by a signal peptide, and at the C-terminus, by a polypeptide comprising at least one portion of the transmembrane domain of a rhabdovirus G protein. Said recombinant novirhabdovirus can be used especially for inducing an immune response to the antigen of interest.
    Type: Application
    Filed: October 8, 2013
    Publication date: September 24, 2015
    Inventors: Michel Bremont, Angella Nzonza